Text size
Teladoc stock is set for a big comeback, says Goldman Sachs.
Courtesy of Teladoc
Teladoc Health
stock has shed half its value in the past six months. An analyst at Goldman Sachs says it’s time to buy shares of the virtual-healthcare firm.
Teladoc (ticker: TDOC) stock was battered in 2021. Though memberships boomed as the pandemic unfolded in 2020, sending the stock up nearly 139% that year, such gains created a high bar that…
